¼¼°èÀÇ ¸® ÁõÈıº Ä¡·á ½ÃÀå : Áúȯ À¯Çüº°, ¾à¹° À¯Çüº°, ¿¬·ÉÃþº°, À¯Åë ä³Îº°, Áö¿ªº°
Global Leigh Syndrome Treatment Market, By Disease Type, By Drug Type, By Age Group, By Distribution Channel, By Geography
»óǰÄÚµå : 1705809
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,197,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,640,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,772,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸® ÁõÈıº Ä¡·á ¼¼°è ½ÃÀåÀº 2025³â¿¡ 2¾ï 7,330¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2032³â¿¡´Â 4¾ï 3,600¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 6.9%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 2¾ï 7,330¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020³âºÎÅÍ 2024³â±îÁö ¿¹Ãø ±â°£ 2025³âºÎÅÍ 2032³â±îÁö
¿¹Ãø ±â°£ : 2025-2032³â CAGR 6.90 2032³â °¡Ä¡ ¿¹Ãø 4¾ï 3,600¸¸ ´Þ·¯
±×¸². ¸® ÁõÈıº Ä¡·á ¼¼°è ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2025³â
Global Leigh Syndrome Treatment Market-IMG1

¸® ÁõÈıº(Leigh's syndrome)Àº ¸® ³úº´ÁõÀ¸·Îµµ ¾Ë·ÁÁ® ÀÖÀ¸¸ç, º¸Åë ¿µ¾Æ±â ¶Ç´Â À¯¾Æ±â¿¡ ¹ßº´ÇÏ´Â Èñ±ÍÇÑ ÁßÁõ ½Å°æ ÁúȯÀÔ´Ï´Ù. ÀÌ ÁúȯÀº Á¤½Å ¹× ¿îµ¿ ´É·ÂÀÇ Á¡ÁøÀûÀÎ »ó½ÇÀ» Ư¡À¸·Î Çϸç, ½É°¢ÇÑ ½Å°æÇÐÀû Àå¾Ö¸¦ À¯¹ßÇϰí, Á¾Á¾ 2-3¼¼ ÀÌÀü¿¡ »ç¸Á¿¡ À̸£°Ô ÇÕ´Ï´Ù. ±×·¯³ª ÀϺΠȯÀÚ´Â ¹ßº´ÀÌ ´À¸®°í »ýÁ¸ ±â°£ÀÌ ±æ¸ç °æ¹ÌÇÑ °æ°ú¸¦ º¸ÀÌ´Â °æ¿ìµµ ÀÖ½À´Ï´Ù. ¸® ÁõÈıºÀº À¯ÀüÀûÀ¸·Î ºÒ±ÕÀÏÇÏ¸ç ´Ù¾çÇÑ À¯ÀüÀÚÀÇ µ¹¿¬º¯ÀÌ¿¡ ÀÇÇØ ¹ß»ýÇÕ´Ï´Ù.

¸® ÁõÈıºÀÇ ¿øÀÎÀÌ µÇ´Â µ¹¿¬º¯ÀÌ´Â ÀϹÝÀûÀ¸·Î ¼¼Æ÷ ³» ¿¡³ÊÁö »ý»ê ±¸Á¶ÀÎ ¹ÌÅäÄܵ帮¾ÆÀÇ ±â´É¿¡ Àå¾Ö¸¦ ÀÏÀ¸Åµ´Ï´Ù. ¸¹Àº °æ¿ì, ¹ÌÅäÄܵ帮¾ÆÀÇ ¿¡³ÊÁö »ý¼º °úÁ¤ÀÇ ÀϺÎÀÎ »êÈ­Àû ÀλêÈ­¿¡ Àå¾Ö°¡ ¹ß»ýÇÕ´Ï´Ù. ÀÌ Àå¾Ö·Î ÀÎÇØ ±¤¹üÀ§ÇÑ ¿¡³ÊÁö ºÎÁ·ÀÌ ¹ß»ýÇÏ¿© ƯÈ÷ ³ú, ±ÙÀ°, ½ÉÀå µî ¿¡³ÊÁö ¼ö¿ä°¡ ¸¹Àº ±â°ü°ú Á¶Á÷¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°è ¸® ÁõÈıº Ä¡·á ½ÃÀåÀº ¾Æ±Þ¼º ±«»ç¼º ³úô¼öÁõ ¶Ç´Â ¸®º´À̶ó°íµµ ºÒ¸®´Â ÀÌ Èñ±ÍÇÑ ½Å°æ À¯Àü¼º ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ Áö³­ ¸î ³â µ¿¾È °ý¸ñÇÒ ¸¸ÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ¸® ÁõÈıºÀº ÁÖ·Î ÁßÃ߽Űæ°è¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ±âÀúÇÙ°ú ³ú°£ÀÇ ¾çÃø¼º º´º¯À» Ư¡À¸·Î ÇÏ´Â Èñ±Í ÁúȯÀ¸·Î, ¹ÌÅäÄܵ帮¾Æ ÁúȯÀÔ´Ï´Ù. º¸Åë ¿µ¾Æ±â³ª À¯¾Æ±â¿¡ ³ªÅ¸³ª¸ç, ¹ß´Þ Áö¿¬À̳ª ÅðÇà, ¿îµ¿ Àå¾Ö, ¼è¾à°¨, ½Ã·Â ¹× û·Â Àå¾Ö µîÀ» À¯¹ßÇÕ´Ï´Ù. È¿°úÀûÀÎ Ä¡·á¹ý °³¹ßÀ» À§ÇÑ ¿¬±¸ Ȱµ¿ÀÇ È°¼ºÈ­¿Í ÀÌ ½É°¢ÇÑ Áúº´¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

±×·¯³ª ³ôÀº Ä¡·áºñ, ½ÂÀÎµÈ Ä¡·á ¿É¼ÇÀÇ ºÎÁ·, Áúº´ ƯÀÌÀû Ä¡·áÀÇ ºÎÁ·, Èñ±Í À¯Àü¼º ÁúȯÀÇ Áø´ÜÀÇ ¾î·Á¿ò µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ½ÃÀå ¼ºÀåÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå °ü°èÀڵ鿡°Ô´Â È¿´ÉÀ» °³¼±ÇÑ ½Å¾à °³¹ß, À¯ÀüÀÚ Ä¡·á ¹× ¹ÌÅäÄܵ帮¾Æ ÀÌ½Ä ¿¬±¸¿¡ ÁýÁß, ÀÓ»ó ¿¬±¸ÀÚ¿ÍÀÇ Çù·Â, ½ÅÈï±¹ ½ÃÀå¿¡¼­ÀÇ °³¹ß µî ´Ù¾çÇÑ ºñÁî´Ï½º ±âȸ°¡ ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷:

Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ¸® ÁõÈıº Ä¡·á ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ¸® ÁõÈıº Ä¡·á ½ÃÀå(Áúȯº°, 2020-2032³â)

Á¦6Àå ¸® ÁõÈıº Ä¡·á ½ÃÀå(¾àÁ¦º°, 2020-2032³â)

Á¦7Àå ¸® ÁõÈıº Ä¡·á ¼¼°è ½ÃÀå, Åõ¿© °æ·Îº°, 2020-2032³â

Á¦8Àå ¼¼°èÀÇ ¸® ÁõÈıº Ä¡·á ½ÃÀå, ¿¬·É ±×·ìº°, 2020-2032³â

Á¦9Àå ¸® ÁõÈıº Ä¡·á ¼¼°è ½ÃÀå, À¯Åë ä³Îº°, 2020-2032³â

Á¦10Àå ¸® ÁõÈıº Ä¡·á ½ÃÀå(Áö¿ªº°, 2020-2032³â)

Á¦11Àå °æÀï ±¸µµ

Á¦12Àå ¼½¼Ç

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Leigh Syndrome Treatment Market is estimated to be valued at USD 273.3 Mn in 2025 and is expected to reach USD 436.0 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 273.3 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.90% 2032 Value Projection: USD 436.0 Mn
Figure. Global Leigh Syndrome Treatment Market Share (%), By Region 2025
Global Leigh Syndrome Treatment Market - IMG1

Leigh syndrome, also known as Leigh disease, is a rare, severe neurological disorder that typically becomes apparent in infancy or early childhood. It is characterized by progressive loss of mental and movement abilities, leading to severe neurological disability and often death by two to three years of age. However, some affected individuals may have a milder course of the disease with later onset and longer survival. Leigh syndrome is genetically heterogeneous, meaning it can be caused by mutations in various genes, and it can be inherited in several different ways, depending on the gene involved:

The mutations responsible for Leigh syndrome typically impair the function of mitochondria, the energy-producing structures within cells. This often involves disruptions in oxidative phosphorylation, which is part of the mitochondrial energy generation process. The disruption results in widespread energy deficiencies, particularly affecting organs and tissues with high energy demands such as the brain, muscle, and heart.

Market Dynamics:

The global Leigh syndrome treatment market has been witnessing notable growth over the past few years owing to the rising prevalence of this rare neurological genetic disorder that is also referred to as subacute necrotizing encephalomyelopathy or Leigh disease. Leigh syndrome is a rare disorder characterized by bilateral lesions in the basal ganglia and brainstem that primarily affects the central nervous system and is a mitochondrial disease. It usually becomes evident in infancy or early childhood and can cause developmental delays or regression, movement problems, weakness, vision/hearing problems, and others. Increasing research activities to develop effective treatment options and rising awareness about this serious illness are fueling the market growth.

However, the market growth can be limited due to factors like high cost of treatment, availability of few approved treatment options, lack of disease-specific treatment, and difficulty in diagnosing this rare genetic disorder. Various opportunities for market players lie in developing novel drugs with improved efficacy, focusing on gene therapy and mitochondrial transplantation research, collaborating with clinical researchers, and expanding in emerging markets.

Key Features of the Study:

Detailed Segmentation:

Table of Contents:

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Leigh Syndrome Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Leigh Syndrome Treatment Market, By Disease Type, 2020-2032, (US$ Million)

6. Global Leigh Syndrome Treatment Market, By Drug Type, 2020-2032, (US$ Million)

7. Global Leigh Syndrome Treatment Market, By Route of Administration, 2020-2032, (US$ Million)

8. Global Leigh Syndrome Treatment Market, By Age Group, 2020-2032, (US$ Million)

9. Global Leigh Syndrome Treatment Market, By Distribution Channel, 2020-2032, (US$ Million)

10. Global Leigh Syndrome Treatment Market, By Region, 2020-2032, (US$ Million)

11. Competitive Landscape

12. Section

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â